GWO, CA39138C1068

Great-West Lifeco crosses 200-day line: Great-West Lifeco stock is 8.76 percent below its high

Published on 10/09/2026 at 15:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Revenue reached CAD 12.72 billion in the second quarter. Great-West Lifeco stock costs EUR 54.75 on October 9, 2026 versus EUR 54.90, down 0.27 percent.
  • Great-West Lifeco crossed its CAD 83.77 200-day moving average on October 9, 2026.
  • The company reported CAD 12.72 billion revenue and CAD 1.09 billion net profit for the second quarter of 2026.
  • Lang & Schwarz quoted the stock at EUR 54.75, down 0.27 percent from EUR 54.90.
  • Barclays raised its target from CAD 87.00 to CAD 91.00 while maintaining an Equal Weight rating.
GWO, CA39138C1068, Illustration mit AI erstellt.

Great-West Lifeco (ISIN CA39138C1068) moved above its CAD 83.77 200-day moving average during trading on October 9, 2026, while its stock last traded at CAD 87.55, according to MarketBeat. The technical move places the Canadian insurer above a widely watched long-term reference level, but the stock remains 8.76 percent below its CAD 95.96 52-week high.

Three dated company milestones

On July 28, 2026, Great-West Lifeco reported CAD 12.72 billion revenue and CAD 1.09 billion net profit for the second quarter, compared with CAD 10.39 billion revenue and CAD 927.00 million net profit a year earlier, according to Markets Insider. On September 29, 2026, Evercore ISI initiated coverage with a Hold rating and a CAD 100.00 price target, the same report said. On October 9, 2026, MarketBeat reported the move above the CAD 83.77 200-day average.

What does the analyst reset imply?

Barclays raised its price target from CAD 87.00 to CAD 91.00 and maintained an Equal Weight rating in a report dated October 8, 2026, according to TipRanks. The CAD 91.00 target is 3.94 percent above the CAD 87.55 Toronto Stock Exchange price cited by MarketBeat, while Evercore's CAD 100.00 target is 14.22 percent higher. The spread shows that analyst views remain positive on earnings and capital generation but vary materially on valuation.

Next date and trading reference

Great-West Lifeco's next earnings date is November 4, 2026, according to Simply Wall St. The date gives investors a clear checkpoint after the second-quarter revenue increase and the latest analyst target changes.

EUR 54.75 in afternoon trading

At Lang & Schwarz, Great-West Lifeco stock was trading at EUR 54.75 on October 9, 2026 at 3:09 p.m. CEST, down 0.27 percent versus the prior close of EUR 54.90 on October 8, 2026. The primary listing is on the Toronto Stock Exchange, where the finance data quote showed CAD 87.55 on October 8, 2026.

The further course of trading is shown by the continuously updated real-time quote of Great-West Lifeco stock.

Great-West Lifeco stock facts

  • Company: Great-West Lifeco Inc.
  • ISIN: CA39138C1068
  • Ticker: GWO
  • Primary exchange: Toronto Stock Exchange
  • Price Lang & Schwarz as of October 9, 2026, 3:09 p.m. CEST: EUR 54.75
  • Change versus prior close: minus 0.27 percent
  • Prior close Lang & Schwarz October 8, 2026: EUR 54.90
  • Market capitalization: CAD 78.4 billion as of October 8, 2026
  • 52-week range: CAD 57.56-CAD 95.96 as of October 8, 2026
  • Sector / Industry: Financial Services / Insurance - Life
  • Next earnings date: November 4, 2026

Market context: Market report S&P TSX Composite.

More news and analyses on Great-West Lifeco stock

Disclaimer...
en | CA39138C1068 | GWO | boerse | 70279226 |